Skip to content

Evaluation of the eyelash booster solution on women with hypotrichosis

Evaluation of safety and efficacy profile of the eyelash booster solution containing stemoxydine and bimatoprost on women with hypotrichosis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042676N36
Enrollment
20
Registered
2024-12-17
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotrichosis of eyelashes.

Interventions

Intervention group: 8 weeks of using Lafarrerr eyelash strengthening serum produced by Dr. Kamkar Laboratory, commissioned by Fartak Lotus Chemical Industries Company containing bimatoprost 0.03%, ace

Sponsors

Fartak Lotus Chemical Industries Company
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18 -65 years old women Idiopathic eyelash hypotrichosis with grade 1 or 2 (with Global Eyelash Assessment (GEA) criteria) Signing the informed consent form

Exclusion criteria

Exclusion criteria: Pregnancy and lactating History of known eye diseases such as glaucoma History of eye surgeries in the last 6 months Eyelash extensions or transplant

Design outcomes

Primary

MeasureTime frame
Comparison of average change in Length, Thickness and eyelash count. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Trichoscopy by fotofinder.;Percentage of people with one grade or more improvement in GEA scale. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Scoring eyelash thickness using digital photos based on Allergan Global Eyebrow assessment (GEA).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026